HCC, the most common type of liver cancer, is globally the third leading cause of cancer mortality after lung and stomach cancer, and a significant problem in Taiwan, mainland China, and other parts of Asia.1 Most patients with HCC are not eligible for surgery or liver transplant, said Theodore Lawrence, M.D., Ph.D., professor and chairman of the Department of Radiation Oncology at the Universit